About Bio-Techne Company
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Bio-Techne's Simple Western Platform Picked by Cizzle for Detection of Cancer Biomarker
Bio-Techne (TECH) and Cizzle Biotechnology, which is developing a blood test for the early detection of lung cancer, said Tuesday that the latter has successfully completed an evaluation program over
Express News | Cizzle And Bio-Techne Completes Evaluation Programme For Detection Of CIZ1B Using ProteinSimple Branded Simple Western Platform
Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western Platform
LONDON and MINNEAPOLIS, Sept. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress evaluating
1. $Prudential(PUK.US)$ - up 3.18%
2. $Science Applications International(SAIC.US)$ - up 1.29%
3. $ICL Group(ICL.US)$ - up 1.01%
4. $Novartis AG(NVS.US)$ - up 0.56%
5. $MGM Resorts International(MGM.US)$ - up 0.4%
1. $VF Corp(VFC.US)$ - down 3.34%
2. $Advanced Drainage(WMS.US)$ - down 0....